Several other hallmark pathologies of AD—overproduction of soluble amyloid beta oligomers, tau hyperphosphorylation, deficits in synaptic plasticity and cell death—appear to converge upon hyperactive GSK3β, and the therapeutic benefit of inhibiting it. The gene discussed is GSK3B; the disease is Alzheimer disease.